Founder & Managing Partner at Invivo Capital - Healthequity, Venture Capital investor in life sciences. PhD, neurosurgeon, Global Executive MBA (IESE). I paint.
THE INSIDE STORY OF AN INVESTMENT/ We are proud to announce that our portfolio company ESOBIOTEC is to be acquired by ASTRAZENECA in a landmark early-stage deal totaling $1B ($425M upfront), only 16 months after our investment. Read here: linkedin.com/posts/lluispare…
PORTFOLIO NEWS/ I’m proud to announce the first investment from our new fund, Invivo Ventures III. Neumirna Tx has secured a €20M Series A, led by Invivo Partners and Angelini Ventures (corporate arm of Angelini Pharma), to develop RNA-based therapies for drug-resistant epilepsy
🏥🚀 Vine a les jornades del #CampusClínicInnova 2024 on ponents destacats parlaran sobre innnovació en salut:
✔️ Disseny de sistemes de simulació en salut
✔️ Teràpies avançades
✔️ El futur de la medicina
✔️ IA en transformació digital
Inscriu-t'hi 👉 i.mtr.cool/tymggnnbgb
Engaging discussion on challenges, trends, and value drivers shaping the C> space, and the potential growth opportunities in Europe at #ATE24
At @InvivoPartners , we believe the C> field will advance into new indications, novel cell types, and cutting-edge technologies.
Lovely summary by Drs Luis Pareras and Cinta Díez at @InvivoPartners in interesting strategies to bypass T cell dysfunction!!! Just amplifying their ideas/concepts of interest!!!
Sam Altman: “Hire for values first, aptitude second, and skills third.”
Most executive recruiters, Sam argues, will reverse this order:
“If you say I need to hire a CFO, they will bring you people with 20 years of experience as a CFO at vaguely similar companies. But unfortunately, it’s usually like 20 years of the exact same year of experience over and over again.”
But if you’re trying to scale fast, values are most important:
“You really need someone who is aligned with the values of the company so that when things change or when they have to make a decision, they’ll make the one you would make if you can’t be there or they will be a good team player and go do that thing.”
Sam continues:
“You need someone who has high aptitude because the role is going to constantly shift. And the rate of learning - the rate of improvement - dominates skills.”
And then skills obviously matter, but for Sam it’s third on the list:
“The very best companies take this exceptionally far in how much they’re willing to hire a non-traditionally qualified executive.”
Video Source: @ycombinator
PODCAST/ Here’s my conversation with Christian @Soschner where we talk about AI, Synbio, Art, and the Future of Mankind. Below is the original post from Christian with the full video (a little over 2 hours).
CLICK HERE TO WATCH THE EPISODE:
lnkd.in/e6_74SgK
The next 5 years in AI (plus Synthetic Biology)/ To understand the 21st century, one must understand where AI & synthetic biology are heading. Here are 9 leading-edge areas that will transform our world (prepared for an ESADE lecture where I will develop them at full length).
9. A New Kind of Science: Unprecedented progress in fields such as quantum mechanics, astronomy, energy, physics, etc., is being driven by AI's application in solving complex scientific problems (would solving the Riemann hypothesis be a valid test of true creative intelligence?)
10. Energy, not compute, will become the primary bottleneck: A gigawatt—akin to running a nuclear plant dedicated solely to training—hasn't been attempted.